TB2012.63 Trust Board Meeting: Thursday 5 July 2012 TB2012.63 Title Status History Development of Strategies for Risk, Assurance and Quality A paper for discussion Board Strategy Workshop 16 May 2012 Audit Committee Workshop 25 June 2012 Quality Committee 26 June 2012 Trust Management Executive 28 June 2012 Board Lead(s) Ms Eileen Walsh, Director of Assurance Mrs. Elaine Strachan-Hall, Chief Nurse Professor Edward Baker, Medical Director Key purpose Strategy Assurance TB2012.63_Development of Strategies for Risk, Assurance and Quality Policy Performance Page 1 of 12 Oxford University Hospitals TB2012.63 Summary The paper presents the proposed strategies to support the Trust’s business, through improved arrangements for the management of risk, quality, and assurance. 1 The development of the strategies underpins the delivery of safe services and managing the Trust’s business efficiently. 2 Implementation plans for each strategy have been developed, subject to approval, which will be overseen by the relevant Executive Director. 3 The strategies were presented for review by the, Audit Committee, Quality Committee and Trust Management Executive meetings in June for discussion. 4 Feedback has been collated from the respective meetings and is presented to the Board to review. 5 Based on the decisions agreed by the Board the updated strategies will be approved and circulated. 6. Recommendations The Board is asked to: review the proposed amendments and points where feedback has differed agree delegated authority to the Chair and Chief Executive to approve the amended strategies TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 2 of 12 Oxford University Hospitals TB2012.63 Introduction 1. The purpose of this paper is to present the collated feedback given on the proposed three strategies which underpin the Trust’s risk management, quality, and assurance agendas. 2. The draft documents were considered by the full Quality Committee, Executive and Non-Executive Directors at the Audit Committee Seminar, and Trust Management Executive during June. Members were invited to discuss the drafts in detail to inform further development of the strategies. Individual Directors have also provided feedback outside of the meetings. 3. This paper summarises the key points raised during discussion. These will be incorporated into the amendments for the final versions. However where points which were raised but views differed, these are presented in this paper for final decision by the Board. 4. The drafts of the strategies discussed at previous meetings have been circulated separately to all Board members. 5. Notwithstanding the Trust’s own objective to have interlinked strategies to support the development of these important agendas, there are a number of external demands on the Trust to have supporting strategies in place in the identified areas. These include Strategic Health Authority development support as part of the Foundation Trust authorisation process, regulatory requirements including Care Quality Commission Essential Standards of Quality & Safety, and NHS Litigation Authority criteria. 6. The strategies will form an important part of developing risk, quality and assurance in the Trust, as a means to support continuous quality improvement, improved management of risk, and assurance provided to the Board on the effectiveness of the system for internal control. Key points across strategies 7. Details of the comments received on each individual strategy have been collated into Appendix 1. A number of common issues were identified across the strategies, namely: 7.1. The strategies should set a clear vision for the next five years, defining clear and measurable goals; 7.2. Implementation plans will need to include timescales which are achievable and realistic with consideration given to resource requirements, including the provision of training for staff; 7.3. The inter-relationship of the strategies should be better described within the documents; 7.4. The strategies should be written in a way that gives context and set out clearly how they are relevant to each staff group; 7.5. The final documents should be of the highest quality in terms of style, format, and content; TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 3 of 12 Oxford University Hospitals 8. TB2012.63 However, a small number of comments were not in agreement and the Board is asked to discuss the individual comments and confirm their decision on each amendment. 8.1. Risk Proximity: The Audit Committee Seminar and the Quality Committee discussed the addition to the risk register of a column noting the proximity of a risk occurring. Both committees agreed that using another colour grading scale would not be appropriate and this will be removed. However, different views on the timescales for noting the proximity of a risk occurring were discussed. The Audit Committee Seminar considered that timescales should be longer and more strategically focussed, while the Quality Committee suggested a more operational approach to the risk occurring: Audit Seminar 12 – months 18 18 months years Quality Committee within months 3 3 - 6 months – 3 3 years or more 6 – 12 months The Trust Management Executive discussed the two differing approaches. It was suggested that to reflect the new performance framework three months would be a more appropriate measure as in terms of performance reporting externally, a serious risk not resolved within three months would result in intervention. 8.2. High Impact / Low Likelihood Risks: The Audit Committee Seminar and Quality Committee both discussed the value of reviewing risks assessed as being of high consequence, but low impact. These risks would not necessarily be escalated to the level that would be reviewed by the committees. The Board is asked to consider whether including this as a separate item within risk register reports would be of value in future, or whether other options should be explored. 9. The Board is asked to discuss the detail of Appendix 1 and to confirm their decisions regarding the issues marked for discussions. Implementing the Risk Strategy 10. The management of risk underpins the delivery of safe services and managing the Trust’s business efficiently. An important part of revising systems will be developing the capacity at all levels to manage risk through education and training. 11. An assessment of the Trust’s risk maturity has been undertaken which was used to inform the Board session considering the Trust’s capacity to manage risk, appropriate tolerances and methods of escalation. These will be supported by TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 4 of 12 Oxford University Hospitals TB2012.63 guidance and tools for staff at each level and published in a Risk Management Handbook for staff. 12. Further work will be undertaken with the Board to set its risk appetite for key areas for the financial year. 13. The supporting documentation will be developed by the Director of Assurance’s team in consultation with specialist staff in Health & Safety and Clinical Governance, and will link into the Trust’s revised performance management framework and reporting. Implementing the Quality Strategy 14. It is vital that the Trust clearly defines its goals in relation to clinical quality such that a consistent message can be articulated both within and outside the organisation. 15. The Quality Strategy has been developed by bringing together existing work streams that relate to safety and quality, whilst articulating the aspirations of the organisation going forward. 16. The development of the Quality Strategy has been managed as a project by the Medical Director and Chief Nurse, together with the supporting frameworks for outcomes, effectiveness and experience. 17. Key members of staff have been engaged in the process of development. 18. The Quality Strategy has been developed to support the maintenance and improvement of clinical quality. An associated implementation plan will be further developed subject to approval of the strategy. Assurance Strategy 19. Building on existing work programmes to strengthen assurance, the assurance strategy has been developed to complement the risk and quality strategies. 20. In addition to the Board Assurance Framework, supporting assurance processes around the management of risk and quality will be incorporated. This will ensure that the Trust is delivering services safely and efficiently and has sufficient means to identify any gaps and monitor the effectiveness of controls. 21. In a similar approach to Internal Audit functions, this includes responsive reviews where further assurance is required or problem areas are identified. Additional tools and supporting processes are described and defined, and how these provide assurance to different audiences. Plan to implement the strategies 22. Overseen by the Executive Directors, senior staff from the teams will be responsible for implementation of the strategies. Each strategy has a supporting plan for implementation. 23. As these three strategies underpin a significant objective for the Trust, it is anticipated that they will be implemented as soon as possible following approval at the July Trust Board meeting. This in turn will support other key objectives such as FT authorisation which requires formal external assessment against the Quality TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 5 of 12 Oxford University Hospitals TB2012.63 Governance Framework, Board Governance Assurance Framework, and an exercise of historical due diligence.. Strategy Approval 24. Based on the decisions reached by the Board in response to the points presented for discussion, the strategies will be finalised and approved. 25. The final strategies will be circulated for the Board Seminar to be held on 19 July 2012. 26. Given timescales, the Board is asked to grant delegated authority to the Chair and Chief Executive to approve the final strategies following amendment. Recommendations 27. The Board of Directors is asked to: 27.1. review and discuss the proposed strategy documents 27.2. agree the points marked for decision in Appendix 1. 27.3. grant delegated authority to the Chair and Chief Executive to approve the strategies Ms. Eileen Walsh, Director of Assurance 28 June 2012 TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 6 of 12 Oxford University Hospitals TB2012.63 Appendix 1: Feedback received on strategy development X The link between the three strategies and how each interrelates needs to be improved X The long term vision is not as clear as that defined in the Quality Strategy X X X X X X X X Audit Committee Trust Management Executive The final strategy needs to be of publishable standard, in terms of presentation, format, and writing style. A one page visual summary should accompany the strategy. Quality Committee Issues to be addressed by amendments Individual Feedback Strategy: Risk Management How the impact of the strategy will be measured needs to be included X The individual and committee responsibilities need to be clarified, including the differentiation between front line staff and management at each level X X The statements on risk and horizon scanning should be stronger, and include definition around positive opportunities and a positive approach to horizon scanning X X It was noted that further work needed to occur with the Board to agree the risk appetite against individual strategic objectives X X The common currency for risk registers should be service level rather than clinical directorate level X X X Strategies refer to Divisional General Managers which should read Clinical Directors X X X Mechanisms need to be clearly described for how risks across the organisation are aggregated, and the process for de-escalation X X X TB2012.63_Development of Strategies for Risk, Assurance and Quality X X Page 7 of 12 Oxford University Hospitals An overview needs to be provided on how risks are captured at ward level and how the system fits together, i.e. through schematic diagrams included in the document TB2012.63 X Training requirements need further review and planning Implementation plans and associated timescales need to be achievable and realistic with consideration given to resource requirements, including the provision of training for staff Implementation plans should describe how the transition from old to new risk registers will take place X X X X X X X Issues for agreement by the Board 1. Risk Proximity: The Audit Committee Workshop and the Quality Committee discussed the addition to the risk register of a column noting the proximity of a risk occurring. Both committees agreed that using another colour grading scale would not be appropriate and this will be removed. However, different views on the timescales for noting the proximity of a risk occurring were discussed. The Audit Committee Workshop considered that timescales should be longer and more strategically focussed, while the Quality Committee suggested a more operational approach to the risk occurring: Audit Committee: 1) 12 – 18 months 2) 18 months – 3 years 3) 3 years or more Quality Committee: 1) within 3 months 2) 3 - 6 months 3) 6 – 12 months 2. High Impact / Low Likelihood Risks: The Audit Committee Seminar and Quality Committees both discussed the value of reviewing risks assessed as being of high consequence, but low impact. These risks would not necessarily be escalated to the level that would be reviewed by the committees. The Board is asked to consider whether including this as a separate item within risk register reports would be of value in future, or whether other options should be explored. TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 8 of 12 Oxford University Hospitals TB2012.63 Quality Committee Audit Committee Trust Management Executive Issues to be addressed by amendments Individual Feedback Strategy: Assurance The final strategy needs to be of publishable standard, in terms of presentation, format, and writing style. A one page visual summary should accompany the strategy. X The link between the three strategies and how each interrelates needs to be improved X X X X The long term vision is not as clear as that defined in the Quality Strategy X X X X X How the impact of the strategy will be measured needs to be included The staff and committee responsibilities need to be clarified, including how assurance relates to different levels of staff The strategy should clarify further how assurances will be used and how they can be used for different audiences, e.g. Patient Groups, or how Governors are assured once FT Membership arrangements are in place X X X X X How assurances will link back to risk registers should be explained The assurance level definitions should be reviewed in comparison to similar measures, e.g. internal / external audit terminology; data quality definitions Distinction should be made between assurance for targets, and assurance of quality, and how this relates to assurance across the totality of the business The Assurance Tools section needs further explanation of how sources of assurance and assurance tools link together and enable the delivery of the strategy TB2012.63_Development of Strategies for Risk, Assurance and Quality X X X X X Page 9 of 12 Oxford University Hospitals Within the healthcare setting an additional mechanism of assurance was defined encompassing the various mechanisms for capturing patient assurance, i.e. through the patients’ experience framework, reactive processes such as complaints and PALS contacts, and surveys The Sources of Assurance examples should include simple, relevant examples such as the assurance level of integrated performance reporting, or how different sources of assurance are brought together through a topic example (Cancer Waits; Delayed Transfers of Care) TB2012.63 X X X Issues for agreement by the Board No areas requiring further discussion were identified through by the various committees/contributors. TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 10 of 12 Oxford University Hospitals TB2012.63 Quality Committee Audit Committee The final strategy needs to be of publishable standard, in terms of presentation, format, and writing style. A one page visual summary should accompany the strategy. X The link between the three strategies and how each interrelates needs to be improved X X X The vision should be further defined in terms of will be the year on year improvement X X X X How the impact of the strategy will be measured needs to be included X The strategy objectives and goals should include how these fit with other agencies, e.g. SHA or PCT priorities X How the Trust aims to deliver an enhanced quality of care through specialist services and the relationship to DGH services should be described X How the impact of the strategy will be measured needs to be included; this should include how the vision translates into actual goals and quality measures Greater emphasis should be included on the Trust’s leadership of quality and interfaces with partners within an Academic Health Sciences Network Trust Management Executive Issues to be addressed by amendments Individual Feedback Strategy: Quality X X X X X The breadth of the strategy could be wider, e.g. considering research, or education X X Improvements are required to diagrams showing committee reporting linkages X TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 11 of 12 Oxford University Hospitals Before approval the strategy should be checked against the Quality Governance Framework TB2012.63 X Issues for agreement by the Board No areas requiring further discussion were identified through by the various committees/contributors. TB2012.63_Development of Strategies for Risk, Assurance and Quality Page 12 of 12